Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Lymphoid 1

Conditions

Obesity 1Lymphoma, Follicular 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Fluorescence Polarization Immunoassay × Clear all
NCT06114498 2026-01-23

Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction

National Medical Research Center for Therapy and Preventive Medicine

Active not recruiting
240 enrolled
LymphoidOther

Lymphoma, Follicular, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡